Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Arch Med Res ; 44(3): 169-77, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23506720

RESUMEN

BACKGROUND AND AIMS: The efficacy of a direct application of plasma needle to in vivo wound healing was experimentally studied in mice. This kind of plasma has achieved considerable success in blood coagulation and tissue restoration in mice. In the development of the present study, an argon plasma needle was chosen for coagulation purposes, whereas for healing purposes, a helium plasma needle was used. METHODS: Treatment was applied with a plasma needle produced by argon and helium to a wound induced in laboratory mice. Tissue regeneration was carried out by three argon plasma treatments with 0.5 SLPM flow for 1 min and three treatments of helium with 1.5 SLPM flow. Intervals between each treatment were 5 min and 60 min for argon and helium plasmas, respectively, thus completing a total treatment time of 180 min. Histological sections were performed to corroborate the internal bleeding and tissue regeneration. RESULTS: After three treatments with argon plasma, the blood produced in the wound was coagulated and protein material appeared. By means of treatment with helium plasma, an approach of the wound edges was produced until the conclusion thereof. These results were corroborated histologically. CONCLUSIONS: This type of acceleration during the skin wound healing process can be attributed to the formation of reactive species such as NO, which were increased in the helium plasma needle with respect to the argon plasma needle.


Asunto(s)
Argón/farmacología , Helio/farmacología , Agujas , Gases em Plasma/administración & dosificación , Gases em Plasma/uso terapéutico , Piel/efectos de los fármacos , Cicatrización de Heridas/efectos de los fármacos , Enfermedad Aguda/terapia , Animales , Argón/administración & dosificación , Argón/uso terapéutico , Helio/administración & dosificación , Helio/uso terapéutico , Ratones , Óxido Nítrico/metabolismo , Gases em Plasma/farmacología , Enfermedades de la Piel/terapia , Factores de Tiempo , Cicatrización de Heridas/fisiología
2.
Am J Trop Med Hyg ; 81(3): 390-5, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19706902

RESUMEN

Here we describe clinical and pathologic evidence of Chagas disease caused in dogs by circulating Trypanosoma cruzi from a newly recognized endemic area in Mexico. We show that the Zumpahuacan isolate, although less virulent than the Sylvio-X10 reference strain that caused acute myocarditis and death, was pathogenic in dogs. Dogs infected with the Zumpahuacan isolate exhibited electrocardiographic alterations, left- and right-ventricle dilation, and hydropericardium. Histologically, diffused perimysial and endomysial lymphoplasmacytic cell infiltration, cardiomyocyte necrosis, and amastigote nests were noted in Zumpahuacan-infected dogs. These findings suggest that the risk of T. cruzi infection and Chagas disease is present in the State of Mexico, and further research is needed to identify the T. cruzi bio-types circulating in southern State of Mexico.


Asunto(s)
Enfermedad de Chagas/veterinaria , Enfermedades de los Perros/parasitología , Trypanosoma cruzi/patogenicidad , Animales , Cardiomiopatía Chagásica/epidemiología , Cardiomiopatía Chagásica/parasitología , Cardiomiopatía Chagásica/veterinaria , Enfermedad de Chagas/epidemiología , Enfermedad de Chagas/parasitología , Enfermedad de Chagas/patología , Modelos Animales de Enfermedad , Reservorios de Enfermedades/veterinaria , Enfermedades de los Perros/epidemiología , Enfermedades de los Perros/patología , Perros , México/epidemiología , Ratones , Ratones Endogámicos BALB C , Miocardio/patología , Virulencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...